Literature DB >> 8487501

Prenatal monitoring of ornithine transcarbamoylase deficiency in two families by DNA analysis.

T Matsuura1, R Hoshide, M Fukushima, T Sakiyama, M Owada, I Matsuda.   

Abstract

We examined the DNA in two families with ornithine transcarbamoylase (OTC) deficiency. Two point mutations of the OTC gene, a C-to-T (codon 141) and a G-to-A (codon 141), were identified. This allowed prenatal monitoring to be made for two fetuses in each family, using polymerase chain reaction (PCR), followed by allele-specific oligonucleotide hybridization or TaqI digestion of amplified sequence. The diagnoses showed heterozygotes of a wild type gene and the corresponding mutant gene in these fetuses; each was confirmed postnatally.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8487501     DOI: 10.1007/bf00711312

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  28 in total

1.  Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency.

Authors:  R P Carstens; W A Fenton; L R Rosenberg
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

2.  Retrospective survey of urea cycle disorders: Part 2. Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies.

Authors:  N Nagata; I Matsuda; T Matsuura; K Oyanagi; K Tada; K Narisawa; T Kitagawa; T Sakiyama; F Yamashita; M Yoshino
Journal:  Am J Med Genet       Date:  1991-09-15

3.  Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene.

Authors:  D Hentzen; A Pelet; D Feldman; D Rabier; J Berthelot; A Munnich
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

4.  Mosaicism for an intragenic deletion in a boy with mild ornithine transcarbamylase deficiency.

Authors:  A Maddalena; D M Sosnoski; G T Berry; R L Nussbaum
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

5.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

6.  Structure of the ornithine transcarbamylase (OTC) gene and DNA diagnosis of OTC deficiency.

Authors:  I Matsuda; A Hata; T Matsuura; T Tsuzuki; K Shimada
Journal:  Clin Chim Acta       Date:  1989-12-15       Impact factor: 3.786

7.  Biochemical heterogeneity of ornithine carbamoyl transferase(OCT) in patients with OCT deficiency.

Authors:  I Matsuda; N Nagata; K Ohyanagi; A Tsuchiyama; H Yamamoto; Y Hase; H Kodama; Y Kai
Journal:  Jinrui Idengaku Zasshi       Date:  1984-09

8.  A human X-Y homologous region encodes "amelogenin".

Authors:  Y Nakahori; O Takenaka; Y Nakagome
Journal:  Genomics       Date:  1991-02       Impact factor: 5.736

9.  Prenatal exclusion of ornithine transcarbamylase deficiency by direct gene analysis.

Authors:  J M Old; P L Briand; S Purvis-Smith; N J Howard; B Wilcken; J Hammond; P Pearson; L Cathelineau; R Williamson; K E Davies
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

10.  DNA analysis for ornithine transcarbamylase deficiency.

Authors:  R Rozen; J E Fox; A M Hack; W A Fenton; A L Horwich; L E Rosenberg
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

View more
  2 in total

1.  Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult.

Authors:  I Matsuda; T Matsuura; A Nishiyori; S Komaki; R Hoshide; T Matsumoto; M Funakoshi; K Kiwaki; F Endo; A Hata; M Shimadzu; M Yoshino
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

2.  Specificity of PCR-SSCP for detection of the mutant ornithine transcarbamylase (OTC) gene in patients with OTC deficiency.

Authors:  R Hoshide; T Matsuura; S Komaki; E Koike; I Ueno; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.